Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Oppenheimer Downgrades GoPro to Perform

Oppenheimer analyst Martin Yang downgrades GoPro (NASDAQ:GPRO) from Outperform to Perform.
byBenzinga Newsdesk
November 4, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Oppenheimer analyst Martin Yang downgrades GoPro (NASDAQ:GPRO) from Outperform to Perform.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

NRx Announces Publication of Initial Findings of BriLife® Vaccine-produced Antibodies Against Omicron Variant; Said Neutralizing Antibody Level Against Omicron Is Approximately 1/3 of the Comparable Antibody Level Against the Original Corona Virus

By Charles Gross
Today, 9:27 AM
 NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage, biopharmaceutical company has received scientific evidence from the Israel Institute for Biological Research (IIBR) that the BriLife® vaccine may produce effective levels of neutralizing antibody against the Omicron variant of the SARS-CoV-2 virus.1 More importantly, many of the mutations (alterations) that cause the Omicron variant spike prot

NRXP